Mortality and Years of Life Lost Due to Brain and Other Central Nervous System Cancer in Wuhan, China, from 2010 to 2019

Overview

Journal Int J Environ Res Public Health

Publisher MDPI

Specialties Environmental Health
Public Health

Date 2023 Feb 25

PMID 36834237

Authors

Jiahao Chen

Yan Liu

Haoyu Wen

Yaqiong Yan

Niannian Yang

Yan Guo

Juan Dai

Chuanhua Yu

Affiliations

Soon will be listed here.

Abstract

Background: Brain cancer is one of the worst types of cancer worldwide. Understanding the epidemiology of CNS cancer is critical for properly allocating healthcare resources.

Methods: We collected data on CNS cancer deaths in Wuhan, China, during 2010-2019. We constructed the cause-eliminated life tables to calculate life expectancy (LE), mortality, and years of life lost (YLLs) by age and sex. The BAPC model was used to forecast the future trends of age-standardized mortality rate (ASMR). Decomposition analysis was adopted to explore the contribution of population growth, population aging, and age-specific mortality to the change in total CNS cancer deaths.

Results: In 2019, the ASMR of CNS cancer was 3.75, and the ASYR was 135.70 in Wuhan, China. ASMR was expected to decrease to 3.43 in 2024. The age distribution of deaths due to CNS cancer was concentrated in the middle-aged and older population, with a peak in the 65-69 age group. Caidian, Jianghan, and Qingshan had the greatest ASMRs in 2019 in Wuhan, with ASMRs of 6.32, 4.78, and 4.75, respectively. Population aging is critical to the change in total CNS cancer deaths.

Conclusion: We analyzed the current status, temporal trends, and gender and age distributions of the burden of CNS cancer in Wuhan, during 2010-2019, providing a valuable reference for better lessening the CNS cancer burden.

Citing Articles

Predictors of mortality at 3 months in patients with skull base tumor resections in a low-income setting.

Shiferaw M, Baleh A, Gizaw A, Teklemariam T, Aklilu A, Awedew A Front Surg. 2024; 11:1398829.

PMID: 39698047 PMC: 11653179. DOI: 10.3389/fsurg.2024.1398829.

References

de Robles P, Fiest K, Frolkis A, Pringsheim T, Atta C, St Germaine-Smith C . The worldwide incidence and prevalence of primary brain tumors: a systematic review and meta-analysis. Neuro Oncol. 2014; 17(6):776-83. PMC: 4483114. DOI: 10.1093/neuonc/nou283. View

. Global, regional, and national age-sex-specific mortality and life expectancy, 1950-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018; 392(10159):1684-1735. PMC: 6227504. DOI: 10.1016/S0140-6736(18)31891-9. View

Johnson K, Cullen J, Barnholtz-Sloan J, Ostrom Q, Langer C, Turner M . Childhood brain tumor epidemiology: a brain tumor epidemiology consortium review. Cancer Epidemiol Biomarkers Prev. 2014; 23(12):2716-36. PMC: 4257885. DOI: 10.1158/1055-9965.EPI-14-0207. View

Kocarnik J, Compton K, Dean F, Fu W, Gaw B, Harvey J . Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019. JAMA Oncol. 2021; 8(3):420-444. PMC: 8719276. DOI: 10.1001/jamaoncol.2021.6987. View

Sun L, Zhou Y, Zhang M, Li C, Qu M, Cai Q . Association of Major Chronic Noncommunicable Diseases and Life Expectancy in China, 2019. Healthcare (Basel). 2022; 10(2). PMC: 8872404. DOI: 10.3390/healthcare10020296. View

Siegel R, Miller K, Fuchs H, Jemal A . Cancer Statistics, 2021. CA Cancer J Clin. 2021; 71(1):7-33. DOI: 10.3322/caac.21654. View

. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Infect Dis. 2018; 18(11):1191-1210. PMC: 6202443. DOI: 10.1016/S1473-3099(18)30310-4. View

Louis D, Perry A, Wesseling P, Brat D, Cree I, Figarella-Branger D . The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol. 2021; 23(8):1231-1251. PMC: 8328013. DOI: 10.1093/neuonc/noab106. View

Yin P, Brauer M, Cohen A, Wang H, Li J, Burnett R . The effect of air pollution on deaths, disease burden, and life expectancy across China and its provinces, 1990-2017: an analysis for the Global Burden of Disease Study 2017. Lancet Planet Health. 2020; 4(9):e386-e398. PMC: 7487771. DOI: 10.1016/S2542-5196(20)30161-3. View

10.

. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018; 392(10159):1736-1788. PMC: 6227606. DOI: 10.1016/S0140-6736(18)32203-7. View

11.

Costa A, Lanca de Oliveira M, Cruz I, Goncalves I, Cascalheira J, Santos C . The Sex Bias of Cancer. Trends Endocrinol Metab. 2020; 31(10):785-799. DOI: 10.1016/j.tem.2020.07.002. View

12.

Ostrom Q, Francis S, Barnholtz-Sloan J . Epidemiology of Brain and Other CNS Tumors. Curr Neurol Neurosci Rep. 2021; 21(12):68. PMC: 8613072. DOI: 10.1007/s11910-021-01152-9. View

13.

Wang W, Yin P, Wang L, Liu Y, Liu J, Qi J . [Analysis on all-cause mortality rate and life expectancy in China, 2005-2018]. Zhonghua Liu Xing Bing Xue Za Zhi. 2021; 42(8):1420-1428. DOI: 10.3760/cma.j.cn112338-20200825-01095. View

14.

Kaderali Z, Lamberti-Pasculli M, Rutka J . The changing epidemiology of paediatric brain tumours: a review from the Hospital for Sick Children. Childs Nerv Syst. 2008; 25(7):787-93. DOI: 10.1007/s00381-008-0771-9. View

15.

Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

16.

Cote D, Ostrom Q, Gittleman H, Duncan K, CreveCoeur T, Kruchko C . Glioma incidence and survival variations by county-level socioeconomic measures. Cancer. 2019; 125(19):3390-3400. PMC: 6744292. DOI: 10.1002/cncr.32328. View

17.

Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Niksic M . Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018; 391(10125):1023-1075. PMC: 5879496. DOI: 10.1016/S0140-6736(17)33326-3. View

18.

Cao M, Li H, Sun D, Chen W . Cancer burden of major cancers in China: A need for sustainable actions. Cancer Commun (Lond). 2020; 40(5):205-210. PMC: 7667573. DOI: 10.1002/cac2.12025. View

19.

Le Rhun E, Weller M . Sex-specific aspects of epidemiology, molecular genetics and outcome: primary brain tumours. ESMO Open. 2020; 5(Suppl 4):e001034. PMC: 7689067. DOI: 10.1136/esmoopen-2020-001034. View

20.

Hou X, Song Z, Zhang F, Liu Z, Long W, Long Z . Burden of brain and other central nervous system cancer in China, 1990-2019: a systematic analysis of observational data from the global burden of disease study 2019. BMJ Open. 2022; 12(7):e059699. PMC: 9297202. DOI: 10.1136/bmjopen-2021-059699. View